Our Recommendations
New Publications
- WHO Science in 5 Episode #78 - mRNA technologies (2022)
- COVID-19 vaccine tracker and landscape (2022)
- Vaccines/COVID-19 vaccine EUL issued (2022)
- AUFKLÄRUNGSMERKBLATT Zur Schutzimpfung gegen COVID-19 (Corona Virus Disease 2019) (Grundimmunisierung und Auffrischimpfung) – mit mRNA-Impfstoffen – (2022)
Filter
14
Featured
Recommendations
9
Language
Document type
Resource Platforms
6
Fact sheets
4
Infographics
2
Videos
2
Countries / Regions
Germany
6
Latin America and the Carribbean
1
Authors & Publishers
Publication Years
Category
COVID-19
6
Information, Education and Communication (IEC)
3
x MEDBOX Issue Brief & Annual Reports x
2
Toolboxes
COVID-19 vaccine tracker and landscape
recommended
The COVID-19 vaccine tracker and landscape compiles detailed information of each COVID-19 vaccine candidate in development by closely monitoring their progress through the pipeline.
The COVID-19 vaccine tracker:
Provides summary tables of COVID-19 vaccine candidates in both clinical and pre-...
mRNA technologies. What is their future and scope, and what are the challenges that countries might face in rolling them out? Hello and welcome to Science in5. I'm Vismita Gupta-Smith. We are talking to Dr.Soumya Swaminathan today. Soumya, talk to us about mRNA technologies. What is the future?
This chronology of facts has challenged public health systems worldwide and regulatory bodies are no exception. Regulatory authorities with mechanisms in place to authorize the use of investigational products had to development guidelines and procedures, create task forces and alliances to maximize ...
Comirnaty® 10 μg und 30 μg von BioNTech / Pfizer und Spikevax® von Moderna
Stand 21. Dezember 2021
Diese Faktenboxen sollen Ihnen helfen, Nutzen und Schaden einer Schutzimpfung gegen COVID-19 abzuwägen. Die Informationen und Zahlen stellen keine endgültige Bewertung dar. Sie basieren auf den derzeit besten wissenschaftlichen Erkenntnissen.
COVID-19 Vaccine Resource Center
recommended
A collection of resources on Covid-19 vaccines, including frequently asked questions, continuing medical education, published research, and commentary.
